MEDISTEM

MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products. The company currently has 16 families of patent applications, Numerous scientific publications, and has out-licensed certain technologies to generate revenue. Medistemโs main candidate, the Endometrial Regenerative Cell is a universal donor pluripotent stem cell, currently being developed for an advanced form of peripheral artery disease called critical limb ischemia.
MEDISTEM
Social Links:
Industry:
Biotechnology
Founded:
2005-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.medisteminc.com
Total Employee:
1+
Status:
Active
Contact:
858-352-7071
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF Amazon Amazon Ohio Region
Similar Organizations
Resonant Medical
Resonant Medical develops, manufactures, and commercializes 3D ultrasound image-guided adaptive radiotherapy products.
Current Employees Featured
Investors List
Alex Tellez
Alex Tellez investment in Series A - Medistem
Official Site Inspections
http://www.medisteminc.com
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149

More informations about "Medistem"
Medistem - Crunchbase Company Profile & Funding
MediStem was founded in 2005 to develop, acquire and commercialize adult stem cell based therapeutic products. The company currently has 16 families of patent applications, Numerous โฆSee details»
Medistem Laboratories - Overview, News & Similar companies
Medistem, Inc., is a clinical stage, San Diego-based regenerative medicines company. The company is focused on the development of Endometrial Regenerative Cells (ERCs), the โฆSee details»
Medistem Laboratories Company Profile | Management and
Medistem, Inc., is a clinical stage, San Diego-based regenerative medicines company. The company is focused on the development of Endometrial Regenerative Cells (ERCs), the โฆSee details»
Medistem Inc. Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Medistem Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Company Medistem Inc - MarketScreener.com
May 10, 2011ย ยท Medistem Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Other OTC: | Other OTCSee details»
Medistem - Products, Competitors, Financials, Employees, โฆ
Medistem, Inc. is developing ERC-124, a universal stem cell product derived from the endometrium. ERC-124 possesses specialized abilities to stimulate new blood vessel โฆSee details»
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.)
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) VentureRadar profile. Find out more about MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) including the โฆSee details»
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc
Mar 8, 2012ย ยท Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases.See details»
Costa Rica - SEC.gov
Medistem Laboratories is an innovative biotechnology company committed to the creation and commercialization of advanced medical therapies based on non-controversial adult stem cells. โฆSee details»
Medistem Inc. Company Summary & News - abnnewswire.net
Medistem, Inc., is focused on the development of the Endometrial Regenerative Cell (ERC), a universal donor adult stem cell product. ERCs possess specialized abilities to stimulate new โฆSee details»
Medistem Inc. Announces New Ticker Symbol Following Reverse
Aug 12, 2008ย ยท Medistem Inc. is a biotechnology company founded to develop and commercialize technologies related to adult stem cell extraction, manipulation, and use for treating โฆSee details»
Biopharmaceutical Executive Dr. Alan Lewis Appointed as CEO
Oct 9, 2012ย ยท Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases.See details»
MediStem Laboratories, Inc.'s Thomas Ichim Appointed CEO
Mar 19, 2008ย ยท Medistem Laboratories is a biotechnology company founded to develop and commercialize technologies related to adult stem cell extraction, manipulation, and use for โฆSee details»
Medistem Signs Exclusive Worldwide License With Yale University โฆ
Mar 12, 2012ย ยท About Medistem Inc. Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating โฆSee details»
Biopharmaceutical Executive Dr. Alan Lewis Appointed ... - Fierce โฆ
Oct 9, 2012ย ยท Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases.See details»
Intrexon to Acquire Medistem to Generate Multipotent Cells
Dec 20, 2013ย ยท Medistem, Inc. is developing ERC-124, a universal stem cell product derived from the endometrium. ERC-124 possesses specialized abilities to stimulate new blood vessel โฆSee details»
Full article: Industry Update: Latest developments in Stem Cell ...
Dec 23, 2012ย ยท Medistem, CA, USA ( www.medisteminc.com) initiated collaboration with Superview Biotechnology ( www.superviewbiotech.com ), a subsidiary of Yinhuan Holding, โฆSee details»
Corporate Governance - MediaTek
MediaTek strictly follows the six core values: Integrity, Conviction Inspired by Deep Thinking, Customer Focus, Constant Renewal, Innovation and Inclusiveness. We have set up various โฆSee details»
Meet Our Corporate Management - MediaTek
Meet MediaTek's Key Managers and view their Corporate Profiles.See details»
MediaTek | Home Page
MediaTek is the global market leader enabling Intelligent Home products. This is where we started, and continue to lead. Connecting you to what matters. Our platforms offer high โฆSee details»